S. 1548 · 117th Congress
ENACT Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
LujánSponsor18 cosponsors · 10 D, 8 R
R
Collins
MB
D
Bennet
BC
D
Casey
KS
D
Sinema
JM
R
Moran
DS
D
Stabenow
TS
D
Smith
JB
R
Boozman
BC
R
Cassidy
EM
D
Markey
GP
D
Peters
RW
R
Wicker
SC
R
Capito
JI
R
Inhofe
LM
R
Murkowski
CB
D
Booker
JH
D
Hickenlooper
MK
D
Kelly1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021
What it does: CRS summary · Introduced in Senate · May 11, 2021
Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021
This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias.
Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must
- establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations;
- operate clinical trials; and
- carry out public outreach to encourage members of minority populations to participate in clinical trials and research.
Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports.
The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: ENACT Act of 2021
Also known as: Equity in Neuroscience and Alzheimer’s Clinical Trials Act of 2021
Latest action (May 11, 2021): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: May 11, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.